Between 2013 and 2023, Luxembourg's market for hormones in dosage (excluding contraceptives and antibiotics) showed a declining trend. The value per capita decreased from $12.3 in 2013 to $7.22 in 2023. The most significant decrease occurred from 2018 onward, with a notable drop from $9.32 to $7.22 in 2023. The year-on-year reduction from 2022 to 2023 was approximately 5.37%, and the CAGR for the past five years (2018-2023) is approximately -4.89%.
Future trends to watch include potential market stabilization due to a growing focus on personalized medicine and biotechnology advancements that could drive new hormone therapies suited to individual needs.
